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ABSTRACT
Mutations in RAB18 have been shown to cause the heterogeneous
autosomal recessive disorder Warburg Micro syndrome (WARBM).
Individuals with WARBM present with a range of clinical symptoms,
including ocular and neurological abnormalities. However, the
underlying cellular and molecular pathogenesis of the disorder
remains unclear, largely owing to the lack of any robust animal models
that phenocopy both the ocular and neurological features of the
disease. We report here the generation and characterisation of a novel
Rab18-mutant mouse model of WARBM. Rab18-mutant mice are
viable and fertile. They present with congenital nuclear cataracts and
atonic pupils, recapitulating the characteristic ocular features that are
associated with WARBM. Additionally, Rab18-mutant cells exhibit an
increase in lipid droplet size following treatment with oleic acid. Lipid
droplet abnormalities are a characteristic feature of cells taken from
WARBM individuals, as well as cells taken from individuals with other
neurodegenerative conditions. Neurological dysfunction is also
apparent in Rab18-mutant mice, including progressive weakness of
the hind limbs. We show that the neurological defects are, most likely,
not caused by gross perturbations in synaptic vesicle recycling in the
central or peripheral nervous system. Rather, loss of Rab18 is
associated with widespread disruption of the neuronal cytoskeleton,
including abnormal accumulations of neurofilament and microtubule
proteins in synaptic terminals, and gross disorganisation of the
cytoskeleton in peripheral nerves. Global proteomic profiling of
peripheral nerves in Rab18-mutant mice reveals significant alterations
in several core molecular pathways that regulate cytoskeletal
dynamics in neurons. The apparent similarities between the WARBM
phenotype and the phenotype that we describe here indicate that the
Rab18-mutant mouse provides an important platform for investigation
of the disease pathogenesis and therapeutic interventions.
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INTRODUCTION
Warburg Micro syndrome (WARBM) is a heterogenous autosomal
recessive disorder (Warburg et al., 1993). Loss-of-function
mutations have been identified in RAB3GAP1 (Aligianis et al.,
2005), RAB3GAP2 (Borck et al., 2011), RAB18 (Bem et al., 2011)
and TBC1D20 (Liegel et al., 2013), and these mutations result in
clinically indistinguishable phenotypes. The clinical features of
WARBM are primarily ocular and neurological (Abdel-Salam et al.,
2007; Derbent et al., 2004; Handley et al., 2013): affected children
have visual impairment and eye abnormalities – including
congenital bilateral cataracts, microphthalmia, microcornea (<10
mm diameter) and small atonic pupils that do not react to dark or
mydriatic agents. Despite early cataract surgery, WARBM
individuals can only perceive light and are effectively blind, 
as a result of progressive optic nerve atrophy, with a 
normal electroretinogram but absent visually evoked potentials.
WARBM individuals are severely neurologically handicapped.
Characteristically, the affected individuals show congenital truncal
hypotonia and, from ~8-12 months, have lower-limb spasticity,
which is progressive and eventually affects the upper limbs, leading
to spastic quadriplegia later in life. Nerve conduction studies show
evidence of a progressive axonal peripheral neuropathy. Affected
children, additionally, have hypothalamic hypogonadism, postnatal
growth retardation and global developmental delay.
RAB proteins function as molecular switches, cycling between
‘inactive’ GDP-bound and ‘active’ GTP-bound conformations in
order to regulate membrane trafficking in a spatially and temporally
restricted manner. RAB protein cycling is governed by four classes
of protein – RAB GDP dissociation inhibitor (GDI), RAB guanine
nucleotide exchange factor (GEF), RAB GDP displacement factor
(GDF) and RAB GTPase activating protein (GAP) (Corbeel and
Freson, 2008; Goody et al., 2005; Stenmark, 2009). RAB3GAP1
(catalytic subunit) and RAB3GAP2 (noncatalytic subunit) form a
heterodimeric enzyme complex, which has GAP activity that is
specific for the RAB3 family of proteins, hydrolysing GTP into
GDP and regulating the Ca2+-mediated exocytosis of hormones and
neurotransmitters (Aligianis et al., 2005; Südhof, 2004). TBC1D20
is a GAP that specifically acts on the RAB1- and RAB2-family
proteins in COPII-dependent endoplasmic reticulum to Golgi
transport (Haas et al., 2007; Nevo-Yassaf et al., 2012). However, the
role(s) of RAB18 in trafficking are still emerging – RAB18 has been
reported to localise to lipid droplets in adipocytes, fibroblasts and
epithelial cells, where it has a role in lipolysis and lipogenesis
(Martin et al., 2005; Ozeki et al., 2005; Pulido et al., 2011).
Localisation to the endoplasmic reticulum and, in variable degrees,
to the Golgi apparatus has also been described (Dejgaard et al.,
2008). In neuroendocrine cells, RAB18 has been reported to regulate
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Ca2+-mediated exocytosis (Vazquez-Martinez et al., 2007). Taken
together, these data suggest that RAB18 has discrete cellular roles
in different cell types (Martin et al., 2005; Ozeki et al., 2005), but
these studies provide no clue as to its role in WARBM disease
pathogenesis.
Rab3gap1 mutant mice and knockout mice (targeting two, three or
four members of the Rab3 subfamily) have previously been
generated (Sakane et al., 2006; Schlüter et al., 2004). None of these
lines recapitulated the major clinical features of WARBM (Sakane
et al., 2006; Schlüter et al., 2004). Rab3gap1 mutant mice are viable,
fertile and live a normal lifespan (Sakane et al., 2006). They show
altered synaptic transmission in vitro, inhibition of Ca2+-mediated
exocytosis of glutamate from cortical synaptosomes and
accumulation of GTP-bound RAB3A in the brain, but only mild
alterations in short-term plasticity in the hippocampal CA1 region.
They show no neurological deterioration and no structural eye, brain
or genital abnormalities (Sakane et al., 2006). Recently, mutations
in Tbc1d20 have been reported in the blind sterile (bs) mouse
(Liegel et al., 2013). These mice exhibit nuclear cataracts from
postnatal day (P)14 and male infertility (Liegel et al., 2013; Varnum,
1983) but do not show any neurological phenotype. No mammalian
models for Rab18 deficiency have been reported, although
morpholino knockdown of the two RAB18 orthologues in zebrafish
results in animals with reduced body size, microphthalmia and
microcephaly, reminiscent of the WARBM phenotype (Bem et al.,
2011). Animal models recapitulating both ocular and neurological
phenotypes of WARBM are required in order to investigate the
ultrastructural and molecular aspects of disease pathogenesis that
cannot be identified through examination of the affected individuals.
Here, we report the generation and characterisation of a novel
Rab18-mutant mouse model of WARBM. Rab18-mutant mice
develop the ocular and neurological phenotypes that are associated
with the human disease, including congenital nuclear cataracts,
atonic pupils and progressive hind limb weakness. The treatment of
cells, derived from the mouse model, to induce lipid droplet
formation results in abnormally large lipid droplets, emphasising a
link between lipid droplets and neurological disease. We show that
the neurological defects in Rab18-mutant mice are not caused by
gross abnormalities in synaptic vesicle recycling, but rather that they
are associated with accumulations of neurofilament and
microtubules in synaptic terminals, and cytoskeletal disorganisation
in the sciatic nerve. Using global proteomic profiling of peripheral
nerves, we reveal alterations in several key pathways that are
involved in the organisation and maintenance of cytoskeletal
architecture in Rab18−/− sciatic nerve.
RESULTS
Rab18−/− mice recapitulate the Warburg Micro syndrome
phenotype
Our initial aim was to create a mouse model of Warburg Micro
syndrome. Rab18-mutant mice were generated from embryonic
stem cells with the Rab18Gt(EUCE0233a03)Hmgu allele (hereafter referred
to as Rab18−), which contains the genetrap vector inserted into
intron 2 of Rab18 (Fig. 1A). The genetrap allele initiates
transcription from the endogenous promoter and prematurely
terminates at the polyadenylation sequence in the FlipRosaβGeo
vector, resulting in a truncated mRNA that encodes a non-functional
protein. To evaluate the impact of the genetrap insertion on Rab18
mRNA expression, reverse transcriptase PCR was performed on
cDNA that had been extracted from embryonic day (E)11.5
embryos. Primers flanking the genetrap insertion site showed very
weak Rab18 expression in Rab18−/− embryos (exons 1-5, Fig. 1B,
top panel). Primers further towards the 3ʹ-end of the cassette (exons
3-7) amplified products in all genotypes, albeit at a lower intensity
in Rab18−/− embryos, indicating alternate transcripts, which could
potentially produce alternate protein isoforms (Fig. 1B, middle
panel). However, quantitative real-time (RT)-PCR that amplified
exons 4-5 in mouse embryonic fibroblasts (MEFs) (Fig. 1C) showed
that any alternate transcripts were present at very low levels, and
western blot analysis of sciatic nerves (Fig. 1D) and mouse
embryonic fibroblasts (Fig. 1E), by using an antibody that targeted
the C-terminus of RAB18, identified no residual RAB18 expression
in Rab18−/− mice, nor any smaller protein isoform. We, therefore,
consider Rab18−/− mice to represent the null phenotype of Rab18.
Rab18−/− mice were viable and fertile. However, both
heterozygote and Rab18−/− mice were found at non-Mendelian
ratios at weaning, but not embryonic stages, suggesting some
perinatal death (supplementary material Table S1). At the time of
eye opening (postnatal day 12), Rab18−/− mice were readily
identifiable by the presence, with complete penetrance, of dense
nuclear cataracts (Fig. 1G), which were absent in the eyes of control
mice (Fig. 1F), and atonic pupils, recapitulating the characteristic
ocular phenotypes that are associated with WARBM. From three
weeks of age, when elevated by the tail, all Rab18−/− mice showed
abnormal hind limb grasping (Fig. 1H, right) compared with control
animals that spread their hind limbs (Fig. 1H, left), indicative of
neurological dysfunction. This abnormal hind limb phenotype
progressed at variable ages to splayed and weak hind limbs. All
mice reaching this stage were culled in accordance with 
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TRANSLATIONAL IMPACT
Clinical issue
Loss-of-function mutations in RAB18, which encodes a ubiquitously
expressed Rab-associated protein, cause the autosomal recessive
disorder Warburg Micro syndrome. Individuals with this disorder present
with abnormalities in the ocular, neurological and endocrine systems, in
addition to postnatal growth retardation. However, little progress has
been made in elucidating the underlying pathology as the families of
affected individuals often decline postmortem examination. Furthermore,
although animal models with mutations in other implicated genes have
been described, none of these have recapitulated both the ocular and
neurological features of the human disease. The effects of knocking out
RAB18 have not been explored in an animal model to date.
Results
In this study, the authors generated and characterised a knockout mouse
model for Rab18. They report that homozygous Rab18 mice display
many of the major ocular and neurological abnormalities that are
associated with Warburg Micro syndrome, including congenital nuclear
cataracts, atonic (constricted) pupils and progressive limb weakness.
The group show that loss of Rab18 is associated with widespread
disruption of the neuronal cytoskeleton – including abnormal
accumulations of neurofilament and microtubule proteins in synaptic
terminals – and gross disorganisation of the cytoskeleton in peripheral
nerves. Global proteomic profiling of peripheral nerves in Rab18-mutant
mice revealed significant alterations in several core molecular pathways
that regulate cytoskeletal dynamics in neurons.
Implications and future directions
This work provides the first animal model that recapitulates the ocular
and neurological abnormalities that are observed in individuals with
Warburg Micro syndrome. The study highlights an important role for
Rab18 in eye development and a previously unknown role in the
maintenance of cytoskeletal organisation in the peripheral nervous
system. The data suggest that the Rab18-knockout mouse represents a
robust model for Warburg Micro syndrome, offering a new experimental

















Home Office guidelines (Fig. 1I). Heterozygote mice were
indistinguishable from their wild-type littermates. Detailed necropsy
analysis was performed on two symptomatic Rab18−/− mice and
littermate controls. The tissues examined were heart, lung, thyroid,
adrenals, testis or uterus, stomach, small intestine, caecum, colon,
mesentery, liver, skin, abdominal mammary, brain (rostral to the
optic chiasm, at the caudal borders of the mammary bodies to
expose the thalamus and caudal section of the hippocampus, and at
the widest point of the cerebellum), pituitary, lower urinary, kidneys,
interscapular brown fat, spleen, pancreas, thymus, lymphosalivary,
head, lumbar and thoracic, and cervical spine and a cross-section of
thigh muscles. No substantial differences were found, suggesting
that the overt phenotypes that were observed in Rab18−/− mice were
not caused by gross disruption of normal development that resulted
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Fig. 1. Rab18−/− mice recapitulate the Warburg Micro syndrome phenotype. (A) Representation of the FlipRosaβGeo genetrap cassette inserted into intron
2 of Rab18. LTR, long terminal repeat; frt and F3, target for FLPe recombinase; loxP and lox5171, targets for Cre recombinase; SA, splice acceptor; βgeo, β-
galactosidase and neomycin phosphotransferase fusion gene as a marker of protein expression; pA, polyadenylation sequence, adapted from Schnütgen et
al., 2005. (B) Reverse-transcriptase PCR on cDNA taken from whole embryos of wild-type (WT), heterozygote (HET) and Rab18−/− mice. The products were
amplified using oligonucleotides that targeted exons 1 and 5 (red arrows in A) and showed weak residual Rab18 transcript in Rab18−/− mice. Amplification
using oligonucleotides that targeted exons 3 and 7 (blue arrows in A) showed slightly reduced transcript levels from the 3′-end of the cassette insertion site in
Rab18−/− mice. β-actin was used as a reaction control. (C) Quantitative RT-PCR on heterozygous (HET) and Rab18−/− mouse embryonic fibroblasts that
amplified exons 3-4 showed no Rab18 transcript in Rab18−/− mice compared with heterozygous littermate controls. The relative expression of Rab18 to the
expression of TBP is shown. (D) Representative western blot analysis on 10 μg of sciatic nerve isolated from wild-type (WT), heterozygous (HET) and Rab18−/−
mice using an antibody targeting the C-terminus of RAB18. The western blot shows a lack of RAB18 protein in Rab18−/− mice. β3 tubulin was used as a
loading control. (E) Representative western blot analysis of heterozygous (HET) and Rab18−/− mouse embryonic fibroblasts. RAB18 protein expression was
lacking in Rab18−/− mouse embryonic fibroblasts, α tubulin was used as a loading control. (F) Slit-lamp picture of the eye of a control mouse. (G) Slit-lamp
pictures showed dense cataracts in adult Rab18−/− mice. (H) Representative images of hind limb clasping in Rab18−/− mice. When elevated by the tail, 
wild-type mice (WT, left) spread their hind limbs, whereas their Rab18−/− littermates (right) clasped their hind paws together. (I) Kaplan-Meirer plot showing the


















from global loss of Rab18 expression but, rather, represented
specific pathological responses in a restricted range of cells and
tissues.
Characterisation of ocular defects in Rab18−/− mice
To further our characterisation of the ocular defects that were
observed in our initial screen of Rab18−/− mice, we performed
histological analysis of haematoxylin- and eosin-stained control and
Rab18−/− eyes at various stages of embryogenesis (Fig. 2). During
embryogenesis, the lens forms from an invagination of the lens
placode, producing a hollow ball of epithelial cells. Cells lining the
posterior of the vesicle then elongate to the anterior, closing the
vesicle by E12.5 (Fig. 2A). At E12.5 in Rab18−/− mice, the posterior
epithelial cells had not reached the lens anterior, suggesting a delay
in development (Fig. 2A,B, arrow in B). By E15.5, the mutant lens
vesicle had closed, but vacuoles had formed at the periphery
(Fig. 2C,D, arrow in D). At P1.5 (Fig. 2E,F), large vacuoles,
pyknotic nuclei and nuclear aggregates were evident, all of which
are characteristic of cataract development (Fig. 2F, arrow).
Individuals with WARBM do not show retinal degeneration and,
similarly, examination of the retina in adult Rab18−/− mice identified
no degeneration (Fig. 2G,H). To examine the cataracts in adult mice,
optical projection tomography was performed on unpigmented
Rab18−/− mice and littermates. Virtual sections through the three-
dimensional reconstruction of the eyes showed a dense nuclear
cataract in the mutant eyes (Fig. 2I,J, arrow in J; supplementary
material Movies 1, 2). Additionally, individuals with WARBM have
permanently constricted pupils, as well as congenital cataracts.
Examination of the pupillary response of Rab18−/− mice to dark, or
to the mydriatic agent tropicamide, showed permanently constricted
pupils in all mutant eyes. Thus, Rab18−/− mice recapitulated the core
ocular phenotypes that are reported in WARBM individuals, and
confirm a key role for RAB18 in eye development.
Loss of Rab18 has no effect on synaptic vesicle recycling in
the PNS or CNS
Given that loss-of-function mutations in any of the known genes –
RAB3GAP1, RAB3GAP2, RAB18 or TBC1D20 – cause a clinically
indistinguishable phenotype (Aligianis et al., 2005; Bem et al., 2011;
Borck et al., 2011; Liegel et al., 2013), we asked whether the
neurological deterioration that was observed in Rab18−/− mice could
be caused by aberrant expression of the RAB3GAP1, RAB3GAP2
or RAB3A proteins. Western blot analysis of isolated synaptic
preparations from Rab18−/−, and control, mouse brains showed no
alterations in the levels of RAB3GAP1, RAB3GAP2 or RAB3A
(supplementary material Fig. S1A-C), suggesting that any
neurological phenotype observed in Rab18−/− mice was not a
consequence of changes in these proteins.
Because RAB3GAP1 and RAB3GAP2 were the first genes found
to be associated with WARBM, previous studies that attempted to
elucidate the pathogenesis underlying WARBM have focused on
dysregulation of synaptic vesicle recycling. Therefore, we utilised
synaptic vesicle recycling assays in the peripheral (PNS) and central
nervous system (CNS) to assess whether loss of RAB18 had any
effect on gross parameters of synaptic transmission (supplementary
material Fig. S1D-N). For analyses in the PNS (supplementary
material Fig. S1D-K), recycling synaptic vesicles at neuromuscular
synapses of lumbrical muscles were labelled with the styryl dye
FM1-43fx (green, supplementary material Fig. S1E,H) and
postsynaptic acetylcholine receptors with tetramethyl-rhodamine
isocyanate (TRITC)-conjugated α-bungarotoxin (BTX, red,
supplementary material Fig. S1D,G). Following membrane
depolarisation with a high potassium solution, all of the nerve
terminals that were examined endocytosed the styryl dye to an equal
degree, irrespective of genotype (supplementary material Fig.
S1J,K). Thus, loss of Rab18 has no major implications on synaptic
vesicle recycling at peripheral synapses.
To examine synaptic vesicle recycling in the CNS (supplementary
material Fig. S1L-N), isolated cortical neuron cultures from wild-
type and Rab18−/− mice were transfected with the genetic reporter
synaptophysin-pHluorin (sypHy) (Granseth et al., 2006). pHluorins
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Fig. 2. Defective pre-natal development of the lens in Rab18−/− mice.
(A,B) At E12.5, Rab18−/− mice showed a delay in the filling of the lens vesicle
through the delayed migration of lens fibre cells from the posterior (B, arrow),
whereas wild-type littermates had a closed lens vesicle (A). By E15.5, the
Rab18−/− lens vesicle had closed, but the first signs of cataract development
(small vacuoles at the lens periphery) were evident (D, arrow). Signs of
cataract formation were absent in controls (C). By P1.5, large vacuoles and
centralised pyknotic nuclei were seen in Rab18−/− lenses (F, arrow) but not in
controls (E). All other ocular structures in control (G) and Rab18−/− lenses (H)
appeared normal, and no retinal degeneration was observed. Note that the
Rab18−/− eye was unpigmented, owing to the origin of the mutation in 129P2-
derived embryonic stem cells; consequently, the retinal pigment epithelium
(arrow in G) was not easily observed. Optical projection tomography
undertaken on adult wild-type (I) and Rab18−/− unpigmented eyes (J) showed
a dense nuclear cataract in the centre of the Rab18−/− lens (arrow in J). Scale















report the pH of their immediate environment. In the case of sypHy,
pHluorin is fused to the second intraluminal domain of
synaptophysin, such that, upon endocytosis, its fluorescence signal
is quenched by the low pH (approximately pH 5.5) of the synaptic
vesicle and, upon exocytosis, fluorescence increases as it encounters
the extracellular medium. To determine how the absence of RAB18
impacts on the kinetics of endocytosis in the CNS, isolated cortical
neuron cultures were stimulated with a train of action potentials
(supplementary material Fig. S1L). The change in sypHy
fluorescence intensity following stimulation was comparable
between wild-type and Rab18−/− neurons. RAB18 deletion did not
affect either sypHy peak response (supplementary material Fig.
S1M, percentage of total vesicle pool – wild-type 32.1±3.4%;
Rab18−/− 30.3±4.3%) or the speed of vesicle endocytosis
(supplementary material Fig. S1N, time constant for endocytosis –
wild-type 42.8±4.7 seconds; Rab18−/− 39.3±3.3 seconds). We
conclude that loss of RAB18 has no effect on synaptic vesicle
recycling in either the PNS or CNS and that deficiency in recycling
is unlikely to underlie the disease process.
Enlarged lipid droplets in Rab18−/− mouse embryonic
fibroblasts
RAB18 has previously been reported to localise to lipid droplets in
adipocytes, fibroblasts and epithelial cell lines (Martin et al., 2005;
Ozeki et al., 2005; Pulido et al., 2011), and has also been identified
as a component of lipid droplets in a proteomics screen (Ozeki et al.,
2005). Furthermore, enlarged lipid droplet size has also been
reported in bs MEFs and TBC1D20-, RAB18- and RAB3GAP1-
deficient fibroblasts that were taken from WARBM individuals
(Liegel et al., 2013). MEFs from control and Rab18−/− embryos
were treated with oleic acid to induce lipid droplet formation and
labelled with the neutral lipid stain BODIPY 493/503. After
24 hours of treatment with oleic acid, we observed no difference in
the number of lipid droplets, but we did observe an enlargement of
lipid droplet size in Rab18−/− MEFs (mean lipid droplet size –
8.89±0.24 pixels in control and 12.82±1.23 pixels in Rab18−/−)
(Fig. 3), consistent with the phenotype that is observed in RAB18-
deficient fibroblasts taken from affected individuals.
Neurofilament accumulation and cytoskeletal
disorganisation in the PNS of Rab18−/− mice
Individuals with WARBM display progressive limb spasticity,
leading to spastic quadriplegia, and also peripheral neuropathy. We
observed progressive hind limb weakness in our Rab18−/− mice and,
therefore, used the Rab18−/− mouse model to investigate the
underlying causes of neuromuscular defects in WARBM individuals.
Initially, we examined whether the observed neuromuscular
dysfunction could be associated with atrophy of skeletal muscles.
The diameters of individual lumbrical muscle fibres were measured,
and no discernible differences were identified at early- or mid-late-
symptomatic timepoints (supplementary material Fig. S2A).
Additionally, the area of motor endplates from control and Rab18−/−
lumbrical muscles was examined, and again, no difference in
morphology or size was observed (supplementary material Fig.
S2B-D).
Because the hind limb phenotype of Rab18−/− mice was not
associated with gross pathological changes in muscle, we proceeded
to examine the integrity of nerve-muscle connectivity at the
neuromuscular junction (NMJ). The NMJ was examined in the
flexor digitorum brevis (FDB) and lumbrical muscles from the hind
paw, and the transverse abdominus (TVA) muscle from the anterior
abdominal wall in early (3-weeks old, onset of hindlimb clasping
phenotype) and mid-late-symptomatic (splayed and weak hind
limbs) Rab18−/− mice, and littermate controls. Postsynaptic motor
endplates (labelled with TRITC-conjugated α-bungarotoxin)
conformed to the normal ‘pretzel’ shape and were normally
innervated in all of the muscle types that were examined (165-kDa
neurofilament and the synaptic vesicle protein SV2) (Fig. 4A-I).
This suggests that the neuromuscular junctions developed normally.
Additionally, no hallmark features of ‘dying-back’ pathology (such
as partial or vacant endplates) were observed in Rab18−/− mice as
hind limb weakness progressed. However, during our analysis of
motor endplate occupancy, we observed that the vast majority of
motor nerve terminals of distal motor axons were grossly abnormal.
NMJs in all three muscle types from Rab18−/− mice showed
distinctive large accumulations at both stages, progressing from 30%
of terminals in early symptomatic muscles to 60% by mid-late-
symptomatic timepoints in FDB and lumbrical muscles (Fig. 4J-K).
The postural TVA muscle also showed abnormal accumulations at
~20% of motor nerve terminals in both early- and mid-late-
symptomatic timepoints (Fig. 4L). Thus, the phenotype was more
severe in those muscles that demonstrated weakness. To determine
715
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Fig. 3. Loss of RAB18 results in the enlargement of lipid droplets in
MEFs. Control (A) and Rab18−/− (B) MEFs that had been treated with oleic
acid for 24 hours were fixed and stained with the neutral lipid stain BODIPY
493/503 (green), cell nuclei were stained by using DAPI (blue).
(C) Quantification of lipid droplet size showed enlarged lipid droplets in
Rab18−/− MEFs. n=3 mice, mean±s.e.m. (mean lipid droplet size – 8.9 pixels
in control MEFs and 12.8 pixels in Rab18−/− MEFs), *P<0.05 using an
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Fig. 4. Rab18−/− mice have large accumulations of neurofilament at the neuromuscular junction. (A-F) Confocal micrographs showing the neuromuscular
junction in (A,D) flexor digitorum brevis (FDB), (B,E) lumbrical and (C,F) transverse abdominus muscle preparations from control (A-C) and Rab18−/− mice (D-
F). TRITC-conjugated α-bungarotoxin staining is shown in red, staining of 165-kDa neurofilament and synaptic vesicle protein SV2 are both shown in green. 
(G-I) Bar charts (mean±s.e.m.) showing that, in all muscles examined – (G) FDB, (H) lumbrical and (I) TVA – the majority of endplates from both early- and mid-
late-symptomatic Rab18−/− mice were fully occupied (where SV2 staining overlayed the endplate). Statistical significance was assessed using a Mann–Whitney
U test. Early symptomatic: FDB P-value=0.5553, muscles from control mice (n=8) and muscles from Rab18−/− mice (n=7); lumbrical P-value=0.8120, muscles
from control mice (n=10) and muscles from Rab18−/− mice (n=8); TVA muscle (n=1). Mid-late symptomatic: FDB P-value=0.3523, muscles from control mice
(n=9) and muscles Rab18−/− mice (n=8); lumbrical P-value=1.0, muscles (n=10); TVA P-value=1.0, muscles (n=3). ns, not significant. (J-L) Bar charts
(mean±s.e.m.) showing the percentage of endplates that exhibited large accumulations (stained green) in Rab18−/− mice at early- and mid-late-symptomatic
timepoints. Statistical significance was assessed using a Mann–Whitney U test. Early symptomatic: FDB P-value=0.0026, muscles from control mice (n=8) and
muscles from Rab18−/− mice (n=7); lumbrical P-value=0.0096, muscles from control mice (n=10) and muscles from Rab18−/− mice (n=8); TVA muscle (n=1).
Mid-late symptomatic: FDB P-value=0.0005, muscles from control mice (n=9) and muscles from Rab18−/− mice (n=8); lumbrical P-value=0.0002, muscles
(n=10); TVA P-value=0.0765, muscles (n=3). ns, not significant, **P<0.005, ***P<0.001. (M-R) Confocal micrographs showing neuromuscular junctions from
Rab18−/− lumbrical muscles that had been immunostained with TRITC-conjugated α-bungarotoxin (red) and one of either neurofilament (NEFM) (M-O) or SV2















the nature of the accumulations, separate immunostaining of motor
nerve terminals and distal axons in lumbrical muscles from mid-late
symptomatic Rab18−/− mice was performed by using antibodies
against one of either 165-kDa neurofilament (Fig. 4M-O) or SV2
(Fig. 4P-R). This showed that the abnormal accumulations contained
neurofilament proteins.
The presence of large accumulations of neurofilaments in motor
nerve terminals suggested that normal cytoskeletal organization was
disrupted in Rab18−/− nerves. Therefore, we examined axonal
architecture in wild-type and mid-late-symptomatic sciatic nerves
using transmission electron microscopy. No abnormalities in
myelination were observed in either genotype (Fig. 5A,B,E-G). At
higher magnification, gross disorganisation of the cytoskeleton with
randomly orientated filaments was observed in sciatic nerves of
Rab18−/− mice (Fig. 5C,D).
Given the cytoskeletal disruption (including disruption of
microtubule networks) in Rab18−/− sciatic nerves, we returned to the
NMJ preparations to establish whether microtubule proteins were
also included in the abnormal accumulations. Immunohistochemical
analysis of the NMJ identified accumulations of β3 tubulin (a
marker for neuronal microtubules) at motor nerve terminals
(Fig. 5F,G). Overall, it appears that loss of Rab18 results in the
disorganisation of microtubule and neurofilament networks in
peripheral nerves.
Global proteomic profiling of peripheral nerves from Rab18-
mutant mice reveals molecular defects in cytoskeletal
dynamics
In order to identify further molecular alterations that might be
associated with the cytoskeletal disorganisation, we used isobaric
tags for relative and absolute quantitation (iTRAQ) mass
spectrometry proteomics to compare global protein abundance in
sciatic nerves from 6-week-old heterozygote (asymptomatic) and
Rab18−/− (symptomatic) mice (n=3 per genotype). The screen
identified 1337 proteins that were altered in abundance. These were
filtered to identify those that had greater than 20% difference in
protein levels between the genotypes and were identified by two or
more unique peptides. Of the 1337 proteins that were identified, 202
proteins met our stringent filtering criteria – the expression of 112
proteins was increased in Rab18−/− mice (supplementary material
Table S2), and the expression of 90 proteins was decreased
(supplementary material Table S3) in Rab18−/− sciatic nerves.
We validated changes in the abundance of two of these proteins
by western blotting extracts from additional sciatic nerves. The 250-
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Fig. 5. Rab18−/− mice have grossly
disorganised cytoskeletons in peripheral
nerves and accumulate microtubules at
the neuromuscular junction.
(A-D) Electron micrographs of the sciatic
nerve in control (A,C) and mid-late-
symptomatic Rab18−/− mice (B,D) showed
normal myelination and normal Remak
bundles in both genotypes. (C,D) Higher-
magnification images showed
disorganisation of the cytoskeleton in the
sciatic nerve of Rab18−/− mice (D) compared
with that of controls (C). The images are
representative of that found in three animals
for each genotype. (E-G) Quantification of
myelination identified no abnormalities in the
G-ratio (G-ratio is the diameter of an axon
divided by the diameter of axon plus myelin).
Statistical significance was tested by using
an unpaired two-tailed Student’s t-test. G-
ratio P-value=0.7610, mice (n=3) (E) or
spread of axon diameter compared with the
G-ratio in control (F) and Rab18−/− mice (G).
(H,I) FDB muscles from wild-type (H) and
mid-late-symptomatic Rab18−/− mice (I) 
were co-stained for β3 tubulin (green,
immunostaining) and TRITC-conjugated α-
bungarotoxin (red). Large accumulations of
microtubules at the NMJ of Rab18−/− mice


















kDa neurofilament heavy chain (NEFH) was reduced in abundance
in both the iTRAQ and western blotting analysis, whereas the
apolipoprotein ApoD was increased in abundance (supplementary
material Fig. S3).
In order to ascertain potential systemic consequences of the
altered protein levels, pathway analysis was performed using
Ingenuity Pathway Analysis (IPA) software. IPA generates
functional networks and pathways from the filtered proteomic data
based on direct and indirect interactions from published literature.
Interestingly, this analysis revealed that a significant number of
proteins with altered abundance in Rab18−/− sciatic nerves were
also associated with other neurodegenerative conditions (Table 1).
These include movement disorders (44 proteins) and
neuromuscular disorders (35 proteins). Importantly, the analysis
also revealed clustering of molecular alterations around pathways
and processes that are associated with cellular association and
organisation (Table 2), including 28 proteins that are known to
regulate organisation of the cytoskeleton and 25 proteins that are
known to mediate microtubule dynamics. Although individual
changes in protein abundance are relatively small, this pathway
analysis suggests that RAB18 expression impacts on a variety of
candidates and downstream regulators for processes that are
involved in cytoskeletal organisation and maintenance. This
proteomic profiling of Rab18−/− sciatic nerve confirmed that
RAB18 plays a key role in the cytoskeletal dynamics of the
nervous system and identified perturbations in several distinct
molecular pathways that are likely to be responsible for
maintaining cytoskeletal function.
DISCUSSION
Mutations in RAB3GAP1, RAB3GAP2, RAB18 and TBC1D20 have
previously been shown to cause the autosomal recessive disorder
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Table 1. Ingenuity pathway analysis highlights the clustering of proteins that are associated with neurological diseases
Number of 
Category Functional annotation Molecules molecules P-value Q-value













P-value, Fisher’s exact test; Q-value Benjamini-Hochberg test.
Table 2. Ingenuity pathway analysis of functional clustering highlights alterations in cellular assembly and organisation
Number of 
Category Functional annotation Molecules molecules P-value Q-value










Morphology of nervous system ASPA,ATP1A2,CAV1,CKB,Ckmt1,CNTF,COL1A1, 20 5.88×10–3 5.37×10–2
CTSD,EPB41L2,FBXO2,GMFB,LAMB2,LMNA, 
MARCKS,NEFH,NEFL,NEFM,PLP1,PRX,SYNCRIP 
Progressive motor neuropathy ANXA2,APOD,BCAS1,CNTF,LDHB,MDH1,NEFH, 17 2.15×10–5 1.54×10–3
NEFL,NEFM,PGK1,RPL13A,RPL15,RPS4X,RTN1,  
THY1,TNXB,TUBA1A
Formation of filaments ACTC1,CAV1,COL6A3,CTNND1,CYB5R3,DYNLL1, 16 2.75×10–5 1.75×10–3
GNG12,KRT14,MIF,NEFH,NEFL,NEFM,POSTN, 
RAP1GDS1,THY1,TUBB
Organisation of organelle ANXA2,BGN,CAV1,COL1A1,COL1A2,DCN,DRP2, 16 1.15×10–4 4.43×10–3
JUP,LAMB2,LMNA,MYH4,NEFH,NEFL,NEFM, 
TNXB,TUBB
Organisation of filaments ANXA2,BGN,COL1A1,COL1A2,DCN,JUP,MYH4, 12 1.66×10–6 2.28×10–4
NEFH,NEFL,NEFM,TNXB,TUBB
Abnormal morphology of axons CKB,Ckmt1,LMNA,NEFH,NEFL,NEFM,PLP1 7 3.83×10–5 2.28×10–3















WARBM, which is characterised by abnormalities that affect the
ocular and neurological systems (Aligianis et al., 2005; Bem et al.,
2011; Borck et al., 2011; Liegel et al., 2013). Mouse models for
Rab3gap1 and Tbc1d20 (bs) have been described previously but fail
to recapitulate the neurological features of the disorder (Liegel et al.,
2013; Sakane et al., 2006). Here, we report the characterisation of a
novel Rab18−/− mouse model that exhibits, with complete
penetrance, both the ocular and neurological features that are
characteristic of the human disease, including congenital nuclear
cataracts, atonic pupils, and hind limb weakness and spasticity. We
have shown that loss of Rab18 does not lead to gross abnormalities
in synaptic vesicle recycling at either PNS or CNS synapses but
does cause widespread disruption of the neuronal cytoskeleton in
peripheral nerves. Proteomic profiling of peripheral nerves revealed
perturbations in several molecular pathways that are known to
regulate cytoskeletal dynamics in the nervous system and/or to be
involved in neurological and neuromuscular disease.
Rab18−/− mice present at the eye-opening stage with dense
nuclear cataracts and atonic pupils. During development of the
murine lens, fibre cells terminally differentiate – laying down a
complex crystalline substructure that is devoid of nuclei and
organelles, thus preventing light scattering and allowing normal
lens transparency (Tholozan and Quinlan, 2007). Histological
analysis of Rab18−/− mice identified a delay in closure of the lens
vesicle at E12.5 and abnormalities in denucleation of fibre cells in
neonates (Fig. 2). Recent studies have highlighted a degree of
similarity between neurons and lens fibre cells, which shows that
they share a comparable morphology with both having an oriented
microtubule system (Frederikse et al., 2012). This suggests there
is a link between the cellular pathology that is observed in the
peripheral nervous system and in the lens fibre cells in Rab18−/−
mice. Furthermore, a previous study of mice that overexpressed
neurofilament light chain reported the development of cataracts,
although further characterisation was not undertaken (Monteiro et
al., 1990). Individuals with WARBM exhibit a broad array of
ocular abnormalities, and the Rab18−/− mice also displayed atonic
pupils, the same pupillary defect that is present in affected
individuals.
RAB18 has previously been reported to localise to lipid droplets,
where it functions in both lipolysis and lipogenesis (Martin et al.,
2005; Ozeki et al., 2005; Pulido et al., 2011). We identified enlarged
lipid droplets in Rab18−/− mouse embryonic fibroblasts, further
pointing towards a role for RAB18 in lipid droplet metabolism.
Lipid droplet abnormalities have also been reported in other motor
neuron diseases. For example, Spg20−/− mice, modelling Troyer
syndrome, show progressive gait defects and increased lipid droplet
numbers in adipose tissue (Renvoisé et al., 2012). A reduced lipid
droplet diameter has also been reported upon knockdown of atlastin,
mutations in which cause hereditary spastic paraplegia, which
causes progressive spasticity similar to that observed in WARBM
(Klemm et al., 2013). Taken together, these data suggest that
neurons are particularly susceptible to abnormalities in lipid droplet
homeostasis. Increased lipid droplet volume has also been reported
in bs MEFs and in fibroblasts taken from individuals with mutations
in RAB3GAP1, TBC1D20 or RAB18. However, at this stage, it is
unclear whether the lipid droplet phenotype is a cause or
consequence of WARBM pathology.
The RAB3GAP1 and RAB3GAP2 proteins have previously been
implicated in regulating synaptic vesicle exocytosis through RAB3
(Sakane et al., 2006; Schlüter et al., 2004), and the neurological
deficits in WARBM individuals have previously been attributed to
a defect in this physiological function. It was therefore surprising
that the Rab18−/− mouse, which recapitulates the affected
individual’s neurological deterioration, revealed no gross
abnormalities in synaptic vesicle recycling at either CNS or PNS
synapses. It is possible that other RAB proteins compensate for the
loss of RAB18 in synaptic vesicle recycling, but not for the major
neuropathological consequence of widespread cytoskeletal
disorganisation in neurons. Our comparison of pathological changes
in the motor neurons that innervate muscles in the hind limb versus
those that innervate the anterior abdominal wall suggests that
neurons with longer axons are more severely affected than those
with shorter axons. Moreover, the spatial and temporal nature of
cytoskeletal accumulations closely matched the overall progression
of weakness that was observed in Rab18−/− mice, which itself might
correlate with the progressive spastic paraplegia that is observed in
individuals with WARBM.
The neurofilament accumulations and cytoskeletal disruption that
we observed are common pathological features of several other
neurodegenerative diseases, including spinal muscular atrophy
(SMA) and Charcot Marie Tooth type 2E (CMT2E) (Miller et al.,
2002; Perrot and Eyer, 2009). Mouse models of SMA also show
presynaptic neurofilament accumulations; however, in these cases,
this is associated with progressive loss of motor axons and skeletal
muscle denervation (Murray et al., 2008). Additionally, mutations
in the neurofilament light gene (NEFL) cause CMT2E, in which
axons are enlarged and disorganised neurofilament accumulates
(Fabrizi et al., 2004). It is interesting that, despite the observed
progression of hind limb weakness in Rab18−/− mice, the mice did
not display any hallmark features of neurodegeneration, such as
abnormalities in skeletal muscles, demyelination or ‘dying-back’
pathology at the NMJ. It is tempting to speculate that the mice might
exhibit reduced nerve conductivity and axonal transport because of
the disruption to the neuronal cytoskeleton that is observed in
peripheral nerves. At this stage we cannot exclude the possibility
that some CNS pathology underlies the spastic paraplegia that we
observed in the Rab18−/− mice; however, no gross pathology was
found upon necropsy of the brain, suggesting that, unlike in the
PNS, any abnormalities in the CNS are not gross but might be more
subtle at the subcellular level.
Our global proteomic analysis of sciatic nerves from heterozygote
and Rab18−/− littermates confirmed that cytoskeletal disorganisation
is a major pathological feature of Rab18−/− nerve, at both the
cellular and molecular level, and revealed significant alterations in
the abundance and/or localisation of a range of proteins that are
involved in cellular assembly and organisation. This could suggest
that there is a defect in trafficking of neurofilaments in Rab18−/−
mice, resulting in accumulations at synaptic terminals and a
reduction in levels of it in the sciatic nerve.
In summary, we report here the generation and initial
characterisation of a novel Rab18−/− mouse model that recapitulates
many of the characteristic clinical features of WARBM. This has
provided us with a foundation in order to begin to understand the
pathobiology that underlies the human disease. We have shown that
loss of Rab18 results in specific abnormalities in the development
of the eye and the composition and/or stability of the neuronal
cytoskeleton. Therapeutic targeting of the molecular pathways found
to be altered in the peripheral nerves of Rab18−/− mice might
provide a starting point for the development of novel therapies for
WARBM. Furthermore, the pathway analysis identified alterations
in the levels of several proteins that are associated with
neuromuscular disease and movement disorders, thus indicating that
Rab18−/− mice might be informative in the context of a wide range
of related diseases.
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Generation of the Rab18−/− mouse
The Rab18 mouse [The European Conditional Mouse Mutagenesis Project;
strain C57BL/6×129P2/Ola (Rab18Gt(EUCE0233a03)Hmgu)] was generated as part
of the European Mouse Disease Clinic (Eumodic) programme by 
the Medical Research Council (MRC) Harwell. Details of genetrap and
targeting can be found at http://www.informatics.jax.org/javawi2/servlet/
WIFetch?page=alleleDetail&key=574626.
Mouse maintenance
Rab18 129P2/Ola and C57BL/6J were maintained as heterozygote breeding
pairs in the animal care facilities at the University of Edinburgh under
standard conditions. Heterozygote Rab18+/− mice on a 129P2/Ola
background were obtained from MRC Harwell. Most analyses were
undertaken on C57BL/6J 129P2/Ola first generation backcrosses. However,
mice crossed to ninth generation C57BL/6J showed the same overt
phenotype. All animal procedures were performed in accordance with Home
Office regulations and institutional guidelines. Litters were genotyped for
heterozygote or homozygote presence of the Rab18 genetrap cassette by
standard PCR protocols.
Reverse transcriptase PCR
RNA was isolated from E11.5 wild-type, heterozygous and Rab18−/−
embryos using the Qiagen RNeasy minikit. cDNA was synthesised from the
resultant RNA using Roche First strand cDNA synthesis kit for RT-PCR
(AMV) (Roche Applied Science) and the resultant mRNA was amplified
using primer pairs directed against Rab18 exon 1 (Ex1aF, 5ʹ-AGAG -
TGGGGTGGGCAAGT-3ʹ) and Rab18 exon 5 (Ex5R, 5ʹ-CAAAGGTG -
TCTCTTCTTGTGACAT-3ʹ); and Rab18 exon 3 (Ex3F, 5ʹ-AAAACGAT -
TTCAGTGGATGGA-3ʹ) and Rab18 exon7 (Ex7aR, 5ʹ-GGTTCTCACT -
TTCCCACAGG-3ʹ). The products were run on a 1% agarose gel.
Preparation and maintenance of MEFs
MEFs were isolated from E13.5 embryos with the head and organs removed
and then minced in Dulbecco’s Modified Eagle’s Medium (DMEM ) (Gibco,
Invitrogen) that contained 10% foetal calf serum (FCS), 1% penicillin and
streptomycin and 3.5μl β-mercaptoethanol (Sigma-Aldrich). The resulting
cells were maintained at 37°C under 5% CO2 and 3% O2.
Quantitative RT-PCR
Quantitative RT-PCR was performed on cDNA that had been isolated from
embryonic fibroblasts using the following probe-primer combinations,
which were designed using the Roche Universal Probe Library software.
Probe number 33, Rab18 Forward 5ʹ-GCTGGTCAAGAGAGGTTCAGA-
3ʹ and Rab18 Reverse 5ʹ-GGTGTCTCTTCTTGTGACATCATAG-3ʹ.
Quantitative RT-PCR was performed on a Lightcycler 480 instrument
(Roche Applied Science), and TATA box binding protein (TBP) was used as
a control gene.
Isolation of crude synaptosomes from brain fractions
Crude synaptosome preparations were generated from the brains of wild-
type, heterozygous and Rab18−/− mice using methods that have been
described previously (Wishart et al., 2012).
Protein extraction and western blot analysis
Protein was extracted from the sciatic nerves of Rab18−/− mice and the
littermate controls. The samples were homogenised in RIPA buffer (Thermo
Scientific) containing 1× protease inhibitor cocktail (Roche Applied
Science), sonicated three times with 30-second pulses, centrifuged at 
16,200 g at 4°C for 15 minutes and then the supernatant was collected.
Protein concentrations were calculated using the Pierce BCA protein assay
kit (Thermo Scientific). 25 μg of crude synaptosomes or 10 μg of sciatic
nerve samples were separated using Novex 4–12% Bis-Tris pre-cast gels
(Life Technologies) and transferred to Hybond nitrocellulose membranes
(Hybond ECL, Amersham Biosciences). The membranes were blocked in
4% milk and then incubated with primary rabbit antibody against RAB18
(Eurogentec custom-made antibody, peptide CESENQNKGVKLSHRE),
rabbit antibody against RAB3GAP1 (Bethyl Laboratories A310-750A),
rabbit antibody against RAB3GAP2 (Abgent, AP9635b) rabbit antibody
against RAB3A (Cell Signaling Technology, catalogue number 3930) and
rabbit antibody against ApoD (Sigma-Aldrich, catalogue number
SAB2700764). A donkey antibody against rabbit IgG and a donkey antibody
against mouse IgG conjugated to horseradish peroxidase (Amersham ECL
western blotting reagent pack) were used as secondary antibodies. The
binding of the antibodies was detected by using the Amersham ECL Plus
western blotting detection system.
Quantitative western blotting Li-COR Odyssey
Protein extraction and electrophoresis was performed as above. The proteins
were transferred to PVDF membranes using the Invitrogen I-Blot transfer
system for 8.5 minutes. The membranes were incubated in Odyssey blocking
buffer for 30 minutes at room temperature before incubation with a primary
antibody directed against neurofilament heavy chain (Abcam, catalogue
number ab8135) in Odyssey blocking buffer overnight at 4°C. Membranes
were then incubated with goat secondary antibody against rabbit IgG
(conjugated to IRDye 680 RD) for 90 minutes at room temperature before
visualisation and quantification using the Li-COR Odyssey scanner (Li-COR).
Total protein stain
Protein extraction and electrophoresis was performed as above. The gels
were stained with Instant Blue (Expedeon) overnight at room temperature
and then washed several times in distilled H2O before visualisation. The
stained gels were visualised on the Li-COR Odyssey scanner or by using the
ImageQuant software.
Cataract histology
Dissected eyes from neonates and E17.5 embryos were fixed in Davidson’s
solution [3 ml 95% ethanol, 2 ml 10% neutral buffered formalin (500 μl
formalin and 4.5 ml phosphate buffer), 1 ml glacial acetic acid and 3 ml
distilled H2O] overnight at 4°C. Embryo heads (E15.5) or intact embryos
(E12.5) were fixed in 4% paraformaldehyde (PFA) in PBS overnight at 4°C.
All samples were dehydrated through an ascending ethanol series and
prepared for paraffin wax embedding. Samples were cut into 7-μm sections
and stained using haematoxylin and eosin to analyse the gross anatomy.
Optical projection tomography
Optical projection tomography was performed on PFA-fixed unpigmented
adult eyes, which were mounted in 1% low melting point agarose,
dehydrated in methanol and then cleared overnight in BABB (1 part benzyl
alcohol, 2 parts benzyl benzoate) as described previously (Sharpe et al.,
2002). The eye was then imaged using a Bioptonics optical projection
tomography scanner 3001 (Bioptonics, Edinburgh, UK) using tissue
autofluorescence (excitation 480 nm, emission 510 nm). The scans were
reconstructed using Bioptonics proprietary software and then rendered using
Drishti software (Ajay Lamaye, ANU, Canberra, Australia). The movies and
stills were created using the same software.
Examination of ocular reflex
One drop of 1% (w/v) tropicamide (Minims) was dropped on the cornea of
Rab18−/− mice. The mouse was left for 5 minutes in order to allow the pupil
to dilate and then the ocular reflex was examined using an indirect
ophthalmoscope light.
Lipid loading of MEFs with oleic acid
Control and Rab18−/− MEFs were isolated as described above. MEFs were
treated with 400 μM oleic acid for 24 hours and labelled with BODIPY
493/503 (Life Technologies) in 150 mM NaCl in H2O for 20 minutes at
room temperature. Five frames per sample were imaged by using identical
microscope settings on a Nikon A1R confocal microscope, and the lipid
droplet area was quantified using the ‘Analyse particles’ ImageJ plugin.
FM1-43fx staining of synaptic vesicle recycling
Mid-late-symptomatic Rab18−/− mice were killed by cervical dislocation and
the muscles were dissected in oxygenated mammalian Ringer solution (120
















mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 0.4 mM NaH2PO4, 23.8
mM NaHCO3 and 5.6 mM D-glucose bubbled with 95% O2 and 5% CO2).
The muscles were stained with bungarotoxin conjugated to TRITC (5
mg/ml, Molecular Probes) for 5 minutes to label postsynaptic acetylcholine
receptors and then washed in oxygenated Ringer for 5 minutes. Recycling
of synaptic vesicles was then stimulated by using high-K+ Ringer solution
(75 mM NaCl, 50 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 0.4 mM NaH2PO4,
23.8 mM NaHCO3 and 5.6 mM D-glucose bubbled with 95% O2 and 5%
CO2) and fluorescently labelled with the styryl dye FM1-43fx (Molecular
Probes, 2.5 μg/ml in high-K+ Ringer) for 15 minutes. Following fluorescent
labelling, the muscles were washed for 15 minutes in oxygenated Ringer,
fixed in 4% PFA (in 1×PBS) for 5 minutes, further washed for 10 minutes
in 1×PBS and mounted with Mowiol (Calbiochem).
Mouse cortical neuron culture
Primary dissociated cortical neuron cultures were prepared from E17.5
Rab18−/− and wild-type embryos and plated at a density of 1.0×107 cells per
coverslip on poly-D-lysine- and laminin-coated coverslips. The cells were
maintained in Neurobasal media containing B27, 0.5 mM L-glutamine and
1% (v/v) penicillin and streptomycin (Invitrogen). After 72 hours, the cells
were supplemented with 1 μM cytosine β-D-arabinofuranoside to inhibit
glial cell proliferation.
Fluorescent imaging with pHluorin reporter
Fluorescent imaging with sypHy was undertaken as reported previously
(Gordon et al., 2011). Cortical neurons were transfected after 7 days in vitro
(DIV) with 1 μg synaptophysin-pHluorin (sypHy; a gift from Leon Lagnado,
LMB Cambridge, Cambridge, UK) by using Lipofectamine 2000, the
neurons were imaged after 14-16 DIV. SypHy-transfected cortical cultures
were mounted in a Warner imaging chamber with embedded parallel
platinum wires (RC-21BRFS) and visualised at 480 nm (>525 nm emission)
using a ×40 oil immersion objective on a Zeiss Axio Observer D1
epifluorescence microscope. The cultures were subjected to continuous
perfusion with imaging buffer (136 mM NaCl, 2.5 mM KCl, 2 mM CaCl2,
1.3 mM MgCl2, 10 mM glucose, 10 mM HEPES, pH 7.4) and were
stimulated with a train of 300 action potentials that were delivered at 10 Hz
(100 mA, 1-millisecond pulse width). Cultures were then subjected to
alkaline imaging buffer (as the imaging buffer with 50 mM NH4Cl
substituted for 50 mM NaCl) to reveal total sypHy fluorescence (total
vesicle pool). Fluorescent images were captured at 4-second intervals using
a Hamamatsu Orca-ER digital camera (Hamamatsu City, Japan), which were
processed offline using ImageJ 1.43 software (National Institutes of Health,
USA). Regions of interest of identical size were placed over nerve terminals,
and the total fluorescence intensity was monitored over time. All statistical
analyses were performed using Microsoft Excel and GraphPad Prism (La
Jolla, CA) software. The pHluorin fluorescence change was calculated as
FΔ/F0, normalised to either the peak stimulus-evoked fluorescence (to
calculate the endocytic time constant – τ) or to the total sypHy fluorescence
revealed with alkali buffer (to calculate the peak evoked sypHy response).
n refers to the number of independent experiments performed.
Muscle preparation
Rab18−/− mice and the littermate controls were humanely killed by cervical
dislocation. The FDB and deep lumbrical muscles (from the hind paw) and
the TVA (from the abdominal wall), were dissected in PBS. The muscles
were fixed in 4% PFA in PBS for 15 minutes (mid-late-symptomatic
animals) or 10 minutes (early-symptomatic animals), and all muscles were
processed for immunohistochemistry.
Immunohistochemistry
All muscles were permeabilised in 4% Triton X-100 in PBS for 1.5 hours
(mid-late symptomatic) or 0.5 hours (early symptomatic) and blocked in 
4% bovine serum albumin and 2% Triton X-100 in PBS for 0.5 hours.
Muscles were then incubated with primary antibodies directed against 
165-kDa neurofilament (2H3 IgG1 supernatant primary, Developmental
Studies Hybridoma Bank), SV2 (IgG1 supernatant primary against 
SV2, Developmental Studies Hybridoma Bank), synaptophysin
(DakoCytomation, catalogue number A0010) or β3 tubulin (Abcam,
catalogue number ab18207) either over two nights (mid-late symptomatic)
or one night (early symptomatic). After 2 hours of washing in PBS, the
muscles were incubated for 10 minutes in TRITC-conjugated α-
bungarotoxin solution and 2.5 hours in swine Alexa-Fluor-488-conjugated
secondary antibody recognising mouse IgG (Dako). Muscles were then
mounted in Mowoil (Calbiochem) on glass slides and coverslips.
Quantification and statistics
All data was collected and analysed using ImageJ and GraphPad Prism 5
software, where mean±s.e.m. Where possible, at least 90 endplates from
each muscle preparation, chosen at random, were assessed. For occupancy
counts, individual motor neuron endplates were classified as being fully
occupied (neurofilament stain entirely covered the endplate), partially
occupied (the neurofilament partially occupied the endplate) or vacant (no
neurofilament was present in the endplate). To calculate the motor endplate
area, images of motor endplates were imported into ImageJ and manually
outlined. To calculate the muscle fibre diameter, three diameter
measurements from isolated muscle fibres were made using ImageJ, and the
mean was then taken. For G-ratio calculations (diameter of the axon divided
by the diameter of the axon plus myelin), transmission electron microscopy
images were imported into ImageJ, and the area of every intact axon and
axon plus myelin was calculated. From this, the diameters were measured
and G-ratio calculated. Statistics were calculated using the Mann-Whitney
test or unpaired Student’s t-test, where appropriate.
Electron microscopy
Both of the sciatic nerves from Rab18−/− mice and the littermate controls
were dissected in PBS and immediately fixed in 4% PFA with 2.5%
glutaraldehyde in PBS for 48 hours at 4°C. The nerves were washed in PBS
and incubated in 1% osmium tetroxide for 30 minutes. Following
dehydration through an ascending series of ethanol solutions and propylene
oxide, the nerves were embedded in Durcupan resin overnight and
polymerised for 48 hours at 50°C. Ultrathin sections (~60 nm) were cut and
collected on formvar-coated grids (Agar Scientific, UK), stained with uranyl
acetate and lead citrate, and then quantitatively assessed in a Philips CM12
transmission electron microscope.
iTRAQ proteomics
Three of each 6-week-old heterozygote and Rab18−/− littermate controls
were humanely killed by using cervical dislocation. All mice used for this
analysis were male, from the same parents and had been backcrossed on to
C57BL/6J for nine generations. The sciatic nerve from each leg was
dissected in PBS and snap-frozen in liquid nitrogen. Nerves from each
genotype were pooled and homogenized in 1:40 (w/v) ratio of 0.5 M
triethylammonium bicarbonate pH 8.5, 1% SDS and 1 mM PMSF and then
sonicated three times with 30-second pulses and centrifuged at 14,400 r.p.m.
at 4°C for 10 minutes. The supernatant was collected for iTRAQ analysis,
performed by Dundee Cell Products.
Proteomic data filtering
Proteomic data was filtered to exclude any protein that was identified by
fewer than two unique peptides, and only those of which the abundance
changed by greater than 20% were taken forwards for pathway analysis, as
previously described (Wishart et al., 2012). It should be noted that six
keratin-family members were identified but could not be excluded because
they met the required filtering criteria.
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